Andrej Sali
Corporate Officer/Principal en The University of California, San Francisco .
Perfil
Dr. Andrej Sali is Co-Founder at Global Blood Therapeutics, Inc. and a Professor at The University of California, San Francisco.
Dr. Sali was previously employed as an Associate Professor by The Rockefeller University and Founder by Prospect Genomix, Inc.
He received his undergraduate degree from the University of Ljubljana and a doctorate degree from the Birkbeck University of London.
Cargos activos de Andrej Sali
| Empresas | Cargo | Inicio |
|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Andrej Sali.
| Empresas | Cargo | Fin |
|---|---|---|
| The Rockefeller University | Corporate Officer/Principal | - |
| Prospect Genomix, Inc. | Fundador | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Fundador | - |
Formación de Andrej Sali.
| University of Ljubljana | Undergraduate Degree |
| Birkbeck University of London | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
| Prospect Genomix, Inc. |
- Bolsa de valores
- Insiders
- Andrej Sali
